AAS
RVMD icon

Ameritas Advisory Services’s Revolution Medicines RVMD Stock Holding History

Ameritas Advisory Services’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.9K Buy
+256
New +$37.4K ﹤0.01% 1257
2025
Q4 		– Sell
-250
Closed -$11.7K – 1888
2025
Q3 		$11.7K Hold
250
– – ﹤0.01% 1605
2025
Q2 		$9.2K Buy
+250
New +$9.6K ﹤0.01% 2046

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Ameritas Advisory Services's RVMD Position: Q2 2026 in Review

Ameritas Advisory Services opened a new position in Revolution Medicines (RVMD) in Q2 2026: 256 shares worth $47.9K. The stake represents ﹤0.01% of the portfolio and ranks #1257 among its holdings. This is a return to the name: Ameritas Advisory Services previously reported a position in RVMD as recently as Q3 2025.

Ameritas Advisory Services first reported a position in RVMD in Q2 2025 and has held it in 3 quarters since. 693 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Ameritas Advisory Services held 256 shares of Revolution Medicines worth $47.9K as of Q2 2026.
  • Revolution Medicines was a new Ameritas Advisory Services position in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #1257 holding.
  • Ameritas Advisory Services first reported a position in Revolution Medicines in Q2 2025 and has held it in 3 quarters since.
  • 693 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.